Global Black Lung Disease Market is expected to grow at an Approximate CAGR of 6.9% during the Forecast Period 2018 To 2023. Black lung disease or coal workers' pneumoconiosis is caused by long exposure to coal dust and is commonly diagnosed in many of the coal miners. The medical condition is characterized by a progressive building of the inhaled coal dust in the lungs, which may lead to inflammation, fibrosis, necrosis, and others.Increasing prevalence of black lung disease is one of the major drivers of market growth during the forecast period. According to the 2005-2016 report of the Health and Safety Executive, it was estimated that the average number of new cases for black lung disease was 25 (on a yearly basis). Moreover, increasing mining activities, increasing research and development expenses, and rising healthcare expenditures boost the market growth. In 2015, according to the Office for National Statistics, the total healthcare expenditure was estimated to about USD 271 billion within U.K.Black Lung Disease Market Segmentation: The global black lung disease market is segmented by the type, diagnosis, treatment, and end-user. On the basis of the type, the market is segmented into simple coal worker's pneumoconiosis, complicated coal worker's pneumoconiosis, and others. On the basis of the diagnosis, the market is segmented into biopsy, imaging, full blood count, pulmonary/lung function tests, physical examination, and others. The imaging segment is segmented into CT, X-ray, and others. On the basis of the treatment, the market is segmented into oxygen therapy, bronchodilators, lung transplant, stem cell therapy, and others. On the basis of the end users, the market is segmented into hospitals & clinics, research organizations & academic institutes, diagnostic centers & labs, and others.Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/5711 .Black Lung Disease Market For Top 10 Players:Boehringer Ingelheim International GmbH (Germany),GlaxoSmithKline plc (U.K),Novartis AG (Switzerland),Teva Pharmaceutical Industries Ltd. (Israel),AstraZeneca (U.K),Koninklijke Philips N.V. (The Netherlands),GENERAL ELECTRIC (U.S.),Siemens AG (Germany),TOSHIBA CORPORATION (Japan),Medtronic (U.S.), and others.Black Lung Disease Market Regional Analysis:The Americas dominates the global Black Lung Disease market owing to the increasingly obese population and increasing rate of cigarette smokers. Additionally, increasing obesity rates along with the increasing healthcare expenditure are likely to enhance the growth of Black Lung Disease in the North American region. For instance, according to the Center for Disease Control and Prevention, in 2015, 1 in 8 American adults had high cholesterol levels. Additionally, around USD 3.2 trillion was spent on healthcare expenditure in the U.S.Europe accounts for the second largest market due to increasing aging mass and increasing obesity rates. Additionally, increasing government initiatives and increasing healthcare spending along with the rising demand for technologically advanced treatments are driving the growth of the Black Lung Disease market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe was aged 65 and above. This increasing older population is likely to drive the growth of the Black Lung Disease market.Asia Pacific is the fastest growing market for Black Lung Disease whose growth is attributed to the rising population which in turn increases the overall patient population, rising population indulging in smoking, and low fiber diet. Additionally, the increasing healthcare expenditure and demand for new treatment options along with the rise in the standard of living are likely to drive the growth of the market. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and increasing demand for diagnostic services.On the other hand, the Middle East and Africa is expected to witness a slow growth due to limited access to healthcare services and affordability issues among individuals. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various chronic diseases.
About US:Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.